In-house roundup: German injunction reform; fintech partnership challenges; plausibility data conundrums

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

In-house roundup: German injunction reform; fintech partnership challenges; plausibility data conundrums

Drugs

Managing IP rounds up the latest news and analysis from patent-focused businesses on German injunctions, fintech partnerships and plausibility conundrums

Drugs

German injunction reform: end injunction gap first say patent holders

Siemens, Nokia, the VDMA and others weigh in on government talks around automatic injunctions and agree that more judges and perhaps a lower hurdle to stay infringement proceedings are needed at the Federal Patent Court. Read more... 

Pharma companies uncertain on data needed for plausibility claims

Drug company lawyers say it is tricky determining the right kind and amount of data to support a claim because courts and examiners have different expectations of sufficiency to determine plausibility. Read more... 

Fintech partnership surge exacerbates negotiation and trade secret challenges

In-house counsel at MasterCard, American Express, MIAX and elsewhere explain how their growing number of fintech partnerships is affecting negotiations and increasing the risk of trade secret and patent litigation. Read more... 

Sign up to receive more content like this in Patent Strategy’s weekly newsletter.



more from across site and SHARED ros bottom lb

More from across our site

An Australian top court decision clarifying honest concurrent use and wins by publishers against AI platforms were also among the top talking points
AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has delayed hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left
Partner Pierre Pérot rejoins the firm he left in 2022 alongside another returning lawyer, associate Camille Abba
Vaping dispute, in which Stobbs and Brandsmiths are the representatives, tested how the UK's Human Rights Act can apply to injunctions restraining unjustified threats
An AI platform being sold for £40m, and lateral hires involving law firms Womble Bond Dickinson and Cadwell Thomas were among the top talking points
With the London Annual Meeting behind us, we look back at some of the lessons learned this week and ahead to what 2027 will bring
Gift this article